Market Soars as IT, Banking Lead Gains; Wipro, MTNL Shine While DMart Slumps on Earnings Miss

The Indian equity markets showed resilience on October 14, closing on a positive note. The Sensex climbed by 591.69 points, or 0.73%, ending at 81,973.05, while the Nifty gained 163.70 points, or 0.66%, to settle at 25,128. A broad-based buying spree across various sectors, except metals, contributed to the rally. Leading the charge were stocks from Information Technology, banking, and real estate, all of which saw gains of around 1%.

Transformers and Rectifiers India Surges on Block Deal

Transformers and Rectifiers India experienced a strong rally, hitting its upper circuit of 5% following a significant block deal worth ₹211 crore. The deal involved 27 lakh shares traded at a floor price of ₹780 per share, which marked a 2.6% discount from the previous closing price. The stock closed at ₹819.30, reflecting investor confidence in the transaction.

MTNL Gains Amid Potential Revival Plan

Mahanagar Telephone Nigam Ltd (MTNL) saw its shares rise by 4.8%, driven by reports suggesting a potential revival plan. The PSU telecom provider, which has a debt exceeding ₹31,000 crore, may avoid the insolvency route if a fund infusion is approved. This news provided a boost to the stock, signaling a possible turnaround for the struggling company.

Premier Energies Rallies on Securing Orders

Premier Energies witnessed a surge, climbing by 10% during trading, though it closed 2.3% higher at ₹1,133. The spike was attributed to the company's announcement of securing multiple orders totaling ₹765 crore. These orders include ₹632 crore for solar modules and ₹133 crore for solar cells, bolstering the company's growth prospects.

Wipro Climbs on Anticipation of Bonus Shares

Wipro shares rose by 4.24% to ₹550.70, as investors showed optimism ahead of an October 17 board meeting. The company is expected to discuss the issuance of bonus shares, which, if approved, would be its fourth bonus issue, following previous ones in 2010, 2017, and 2019. The news of the possible corporate action spurred interest in the stock.

Hindustan Construction Receives Major Contract

Hindustan Construction Company saw a 3.5% rise in its stock price, closing at ₹43.74. The increase was driven by news of the company securing a ₹1,031.6 crore contract from the Maharashtra State Road Development Corporation. The project involves constructing a two-lane bridge across Agardanda Creek, boosting investor confidence in the company's future prospects.

Avenue Supermarts Tumbles After Earnings Disappointment

Avenue Supermarts, the parent company of DMart, saw its stock plummet by over 8%, closing at ₹4,191. The sharp decline was due to disappointing Q2 earnings, where both revenue and net profit failed to meet expectations. The company reported the slowest revenue growth in four years, raising concerns about future performance.

Bajaj Housing Finance Drops as Lock-in Period Ends

Bajaj Housing Finance shares fell by 6% to ₹142, coinciding with the expiration of a one-month lock-in period for anchor investors. With 12.6 crore shares, or 2% of the company's equity, now eligible for trading, this increase in supply put pressure on the stock price, according to a note from Nuvama Alternative & Quantitative Research.

Tata Chemicals Falls on Profit Booking

Tata Chemicals' stock declined by over 7%, closing at ₹1,099, as investors engaged in profit booking after a recent rally. Despite the drop, technical indicators, including Bollinger Bands and moving averages, suggest the stock remains in a bullish trend. The overall outlook is positive, as indicated by daily, weekly, and monthly RSI readings.

Sudarshan Chemical Industries Sheds Gains After Rally

After a stellar rally in the previous session, shares of Sudarshan Chemical Industries fell by 7.5%, ending at ₹1,111. The earlier surge had been triggered by the announcement of acquiring Heubach's global pigment business for ₹1,180 crore. However, profit booking led to a reversal of fortunes for the stock.

Indian Energy Exchange Under Pressure Due to Market Coupling Concerns

Indian Energy Exchange (IEX) shares fell 4.3% to ₹195.70 amid renewed concerns about market coupling. The Power Secretary confirmed that work on the market coupling mechanism is ongoing, which has been a persistent overhang for the stock. Despite the decline, the company's strategic positioning in the energy market remains strong.

Conclusion

The Indian stock market saw a mix of positive and negative movements on October 14, reflecting investor sentiment across different sectors. While companies like Wipro, MTNL, and Premier Energies showed gains on specific news and developments, others like Avenue Supermarts and Bajaj Housing Finance faced selling pressure due to broader concerns. Overall, the market closed in the green, driven by robust performance from IT and banking stocks, suggesting a cautiously optimistic outlook.

Freshara Agro Exports Ipo Gmp

Lakshya Powertech Ipo Gmp

Hyundai Motor India Ipo Gmp

Pranik Logistics Ipo Gmp

CCI Clears Mankind Pharma's Rs 13,630-Crore Acquisition of Bharat Serums and Vaccines

On October 1, 2024, the Competition Commission of India (CCI) approved Mankind Pharma's acquisition of Bharat Serums and Vaccines for Rs 13,630 crore. The acquisition marks a significant strategic move by Mankind Pharma, a publicly listed company renowned for developing, manufacturing, and marketing a diverse range of pharmaceutical finished dosage formulations.

Key Details of the Acquisition

In July 2024, Mankind Pharma announced its plans to fully acquire Bharat Serums and Vaccines from private equity firm Advent International. This acquisition involves the purchase of 100 percent of Bharat Serums and Vaccines for an enterprise value of Rs 13,630 crore. The deal positions Mankind Pharma as a major player in the women's health and fertility drug market, while also providing access to critical care products and advanced R&D platforms that have high barriers to entry.

Bharat Serums and Vaccines' Expertise

Bharat Serums and Vaccines Ltd (BSV) has a strong presence in women's healthcare, assisted reproductive treatment, and critical care medicine. The company is engaged in various pharmaceutical activities, including research, development, licensing, manufacturing, and marketing of pharmaceutical formulations, APIs, food supplements, and health products. BSV's focus on complex R&D platforms will further strengthen Mankind Pharma's product portfolio, allowing it to enter new high-growth areas in the pharmaceutical market.

Strategic Benefits for Mankind Pharma

This acquisition not only expands Mankind Pharma's portfolio but also strengthens its position in the Indian pharmaceutical industry, particularly in niche segments like women's healthcare and emergency medicine. The deal is expected to enhance Mankind's competitive edge, giving it access to BSV's proprietary biopharmaceutical products, complex drug formulations, and cutting-edge R&D capabilities. By leveraging these assets, Mankind Pharma is poised to grow its footprint in both domestic and international markets.

Regulatory Approval and Fair Competition

The deal, like all large acquisitions, required approval from the CCI to ensure it complied with fair competition laws. The CCI's mandate is to promote healthy competition in the marketplace and prevent unfair business practices. With this approval, Mankind Pharma has cleared a crucial regulatory hurdle, paving the way for the full integration of Bharat Serums and Vaccines into its operations.

This acquisition is expected to be a game-changer for Mankind Pharma, positioning it for sustained growth in highly specialized sectors and expanding its reach in the global pharmaceutical industry.

Garuda Construction and Engineering Ipo Gmp

HVAX Technologies Ipo Allotment

Saj Hotels Ipo Allotment

khyati global ventures limited ipo gmp

NeoPolitanPizza and Food Ipo Gmp

Subam Papers Ipo Gmp

Paramount Dye Tec Ipo Gmp

SEBI Study Reveals 93% of Individual F&O Traders Faced Losses Between FY22 and FY24

A recent study conducted by the Securities and Exchange Board of India (SEBI) has revealed that nearly 93% of individual traders participating in the futures and options (F&O) market faced significant financial losses over the past three fiscal years, spanning from FY22 to FY24. The analysis covered over 1 crore investors, with most experiencing average losses of approximately Rs 2 lakh each.

Key Highlights of the Study:

• Aggregate Losses: Individual traders in the F&O market collectively suffered Rs 1.8 lakh crore in total losses during the period.
• Loss Concentration: Among the worst-hit traders, the top 3.5% (approximately 4 lakh traders) faced an average loss of Rs 28 lakh each, including transaction costs.
• Minority Gained: Only 1% of individual traders managed to secure profits exceeding Rs 1 lakh, even after factoring in transaction costs.

This report follows a similar SEBI study published in January 2023, which indicated that 89% of individual equity F&O traders had incurred losses in FY22. The updated analysis expands on this by examining three fiscal years and providing a more comprehensive view of individual traders' profit and loss patterns.

Insights from the SEBI Report

The study shows a clear disparity between individual and institutional traders. While individual traders struggled to turn profits, proprietary traders and foreign portfolio investors (FPIs) saw notable gains. Specifically, proprietary traders earned Rs 33,000 crore in gross trading profits, and FPIs made Rs 28,000 crore in FY24, before transaction costs.

Interestingly, 97% of FPI profits and 96% of proprietary trading gains were attributed to algorithmic trading, highlighting the dominance of technology-driven strategies in profit generation. This contrasts sharply with the results of individual traders, who spent an average of Rs 26,000 per person on transaction costs in FY24. Over the three years, individuals collectively spent around Rs 50,000 crore on transaction fees, with brokerage charges accounting for 51% of these costs and exchange fees representing 20%.

Trading Patterns and Demographics

The SEBI study also sheds light on the changing demographic patterns in the F&O market:

• Increased Youth Participation: The proportion of young traders (below 30 years) surged from 31% in FY23 to 43% in FY24.
• Geographical Shifts: Traders from Beyond Top 30 (B30) cities made up 72.2% of the total F&O trader base, surpassing the percentage of mutual fund investors (61.7%) from these regions.

Despite the high rate of losses, more than 75% of individual traders continued to trade in F&O markets across consecutive years. This persistence in trading, despite repeated financial setbacks, indicates either a strong belief in potential gains or a lack of understanding of the risks involved.

Income and Financial Profiles

The study also examined the income profiles of F&O traders. Notably:

• Over 75% of traders declared annual incomes of less than Rs 5 lakh in FY24, yet they actively participated in high-risk, high-cost F&O trading.
• The distribution of losses and costs disproportionately affected lower-income traders, raising concerns about the financial literacy and risk management practices of these individuals.

Broader Implications

The findings of this study are significant, particularly as the F&O market has seen an influx of individual participants in recent years. The results highlight the substantial financial risks associated with trading in F&O markets for individual investors, especially those with limited resources and knowledge.

While institutional traders, often equipped with sophisticated algorithms and strategies, continue to profit, the vast majority of individual traders face considerable losses, raising questions about market fairness, accessibility, and the adequacy of investor protection mechanisms.

This report serves as a reminder for individual investors to exercise caution, consider their financial capacities, and seek professional advice before engaging in F&O trading.

Wol 3D India
Rappid Valves
Manba Finance
SD Retail Logo
Avi Ansh Textile
Phoenix Overseas
Kalana Ispat

MCX Trading Resumes After Technical Glitch

On February 13, 2024, the Multi Commodity Exchange of India (MCX) faced a significant delay in trading due to a technical glitch. Initially scheduled to begin at 9 AM, the exchange was forced to revise its trading hours multiple times throughout the morning. First, the opening was postponed to 10 AM, then to 11 AM, and finally, trading commenced at 1 PM. This delay affected the commodity derivatives segment, leading to widespread disruptions.

According to a circular issued by MCX, the technical issues stemmed from its commodity derivatives trading platform. Both MCX's internal team and its technology partner, Tata Consultancy Services (TCS), were actively working to fix the problem. Zerodha and Upstox, two prominent brokerage firms, were among the first to report the delay via Twitter.

Despite the technical difficulties at MCX, the overall market showed resilience. By the time trading resumed at 1 PM, the Sensex had climbed 0.2% to reach 71,191 points, reflecting marginal gains in the equity markets. Brokers, however, expressed concerns about delays in receiving key files—such as position, margin, and trade files—from MCX, which affected the processing of trades from the previous session.

Shrey Jain, founder and CEO of SAS Online, stated, "Brokers are awaiting their position, margin, and trade files from the MCX. Without these, the processing of the previous trading session remains pending. Once the files are received, we will complete the beginning-of-day process and prepare the system for today's trading." This incident underscores the importance of technological reliability in modern financial markets, where even short-term glitches can have significant ripple effects. The incident has sparked a discussion on the robustness of India's trading platforms and their contingency plans in the event of technical failures.

krn heat exchanger ipo gmp

best indian movies on netflix

manba finance ipo gmp

Globus Spirits Stock Jumps 4% After Launching Luxury Whisky DOAAB

Shares of Globus Spirits Limited surged 4% to ₹1,370 in morning trading on September 17, 2024, following the company's entry into the luxury whisky market with its new product, DOAAB India Craft Whisky. This marks Globus Spirits' foray into the high-end whisky segment, bringing a fresh perspective to the growing market.

The new range, named DOAAB India Craft Whisky, draws its inspiration from the Hindi term "DOAAB," meaning "the land between two rivers," symbolizing a blend of diverse influences. The first release in this limited-edition series, "Six Blind Men and the Elephant," is a single malt whisky aged exclusively in ex-bourbon barrels. With only 500 casks produced, this edition represents a blend of artisanal craftsmanship and storytelling, inspired by the Indian fable of the same name.

Earlier this month, Motilal Oswal Mutual Fund acquired 2 lakh equity shares, amounting to a 0.69% stake in Globus Spirits, through a block deal on the NSE.

Globus Spirits, which produces, markets, and sells branded Indian-made foreign liquor and bulk alcohol, operates five fully integrated grain-based distilleries across India, with a combined annual capacity of around 268 million liters.

As of 11:10 am, the company's shares were trading at ₹1,335, reflecting a gain of over 1% on the NSE. Over the past month, Globus Spirits' share price has climbed more than 55%.

IPO GMP

Bollywood News

Telegram Channel for Bank Nifty Calls